Page last updated: 2024-11-13

ascorbic acid 2-sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID54676864
CHEMBL ID1161233
CHEBI ID167715
SCHEMBL ID290720
MeSH IDM0042371

Synonyms (18)

Synonym
37627-95-5
[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-uran-4-yl] hydrogen sulate
l-ascorbic acid 2-sulfate
CHEBI:167715
l-ascorbic acid, 2-(hydrogen sulfate)
ascorbic acid 2-sulfate
CHEMBL1161233
[(5r)-5-[(1s)-1,2-dihydroxyethyl]-2-hydroxy-4-oxofuran-3-yl] hydrogen sulfate
2jwh465tw2 ,
unii-2jwh465tw2
l-ascorbic acid, 2-hydrogensulfate (ester)
niosh/ci7668000
l-ascorbate-2-sulfate
CI76680000
SCHEMBL290720
DTXSID80958676
2-o-sulfohex-1-enofuranos-3-ulose
[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] hydrogen sulfate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
butenolideA gamma-lactone that consists of a 2-furanone skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID232873Free radical scavenging assessed as color reduction of DPPH2002Journal of medicinal chemistry, Jan-17, Volume: 45, Issue:2
Synthesis and characterization of a series of novel monoacylated ascorbic acid derivatives, 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids, as skin antioxidants.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (51.85)18.7374
1990's7 (25.93)18.2507
2000's5 (18.52)29.6817
2010's1 (3.70)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (7.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (92.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]